Julia Szekeres-Bartho

Articles in Scholarly Journals [Incomplete List]

  1. A pivotal role for galectin-1 in fetomaternal tolerance
    Nature Medicine, vol. 13, no. 12, Article ID nm1680, 7 pages, 2007
  2. Progestagen therapy for recurrent miscarriage
    Human Reproduction Update, vol. 14, no. 1, pp. 27–35, 2007
  3. Progesterone During Pregnancy: Endocrine?Immune Cross Talk in Mammalian Species and the Role of Stress
    American Journal of Reproductive Immunology, vol. 58, no. 3, pp. 268–279, 2007
  4. «Reproductive Immunology – an Update»
    Transfusion Medicine and Hemotherapy, vol. 34, no. 1, pp. 54–54, 2007
  5. Reproductive Immunology – an Update
    Transfusion Medicine and Hemotherapy, vol. 33, no. 6, pp. 474–485, 2006
  6. The Progesterone-Induced Blocking Factor Modulates the Balance of PKC and Intracellular Ca++
    American Journal of Reproductive Immunology, vol. 55, no. 2, pp. 122–129, 2006
  7. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks
    Journal of Maternal-Fetal and Neonatal Medicine, vol. 17, no. 5, pp. 353–356, 2005
  8. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage
    BJOG: An International Journal of Obstetrics and Gynaecology, vol. 112, no. 11, pp. 1585–1585, 2005
  9. The Impact of Dydrogesterone Supplementation on Hormonal Profile and Progesterone-induced Blocking Factor Concentrations in Women with Threatened Abortion
    American Journal of Reproductive Immunology, vol. 53, no. 4, pp. 166–171, 2005
  10. Physiology Should be Supported with Evidence in Progesterone Administration for Threatened Miscarriage - Authors' Reply
    American Journal of Reproductive Immunology, vol. 54, no. 6, pp. 397–397, 2005
  11. Spectrin breakdown products in the cerebrospinal fluid in severe head injury – preliminary observations
    Acta Neurochirurgica, vol. 147, no. 8, pp. 855–861, 2005
  12. PIBF(progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome
    International Journal of Cancer, vol. 112, no. 1, pp. 51–60, 2004
  13. Urinary Progesterone-Induced Blocking Factor Concentration Is Related to Pregnancy Outcome
    Biology of Reproduction, vol. 71, no. 5, pp. 1699–1705, 2004
  14. gamma/delta T cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy
    Clinical and Experimental Immunology, vol. 131, no. 2, pp. 287–291, 2003
  15. gamma/deltaT-cell Subsets, NKG2A Expression and Apoptosis of Vdelta2+ T cells in Pregnant Women with or without Risk of Premature Pregnancy Termination
    American Journal of Reproductive Immunology, vol. 50, no. 6, pp. 490–496, 2003
  16. Impaired Reproduction of Histamine Deficient (histidine-decarboxylase Knockout) Mice is Caused Predominantly by a Decreased Male Mating Behavior
    American Journal of Reproductive Immunology, vol. 50, no. 2, pp. 152–158, 2003
  17. Progesterone Regulates IL12 Expression in Pregnancy Lymphocytes by Inhibiting Phospholipase A2
    American Journal of Reproductive Immunology, vol. 49, no. 1, pp. 1–5, 2003
  18. IMMUNOLOGICAL RELATIONSHIP BETWEEN THE MOTHER AND THE FETUS
    International Reviews Of Immunology, vol. 21, no. 6, pp. 471–495, 2002
  19. Decrease in CD3-negative-CD8dim+ and V?2/V?9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection
    Journal of Hepatology, vol. 37, no. 4, pp. 514–522, 2002
  20. Progesterone Induced Blocking Factor (PIBF) Mediates Progesterone Induced Suppression of Decidual Lymphocyte Cytotoxicity
    American Journal of Reproductive Immunology, vol. 48, no. 4, pp. 201–209, 2002
  21. Progesterone as an immunomodulatory molecule
    International Immunopharmacology, vol. 1, no. 6, pp. 1037–1048, 2001
  22. Journal of Assisted Reproduction and Genetics, vol. 18, no. 11, pp. 603–607, 2001
  23. The role of? / dT cells in the feto-maternal relationship
    Seminars in Immunology, vol. 13, no. 4, pp. 229–233, 2001
  24. Cyclooxygenase is involved in the effects of progesterone-induced blocking factor on the production of interleukin 12
    American Journal of Obstetrics and Gynecology, vol. 183, no. 1, pp. 126–130, 2000
  25. Th2 biased immune response in cases with active Mycobacterium tuberculosis infection and tuberculin anergy
    FEMS Immunology and Medical Microbiology, vol. 22, no. 3, pp. 199–204, 1998
  26. Interaction of AU-rich sequence binding proteins with actin: Possible involvement of the actin cytoskeleton in lymphokine mRNA turnover
    Journal of Cellular Physiology, vol. 173, no. 1, pp. 19–27, 1997
  27. The Antiabortive Effect of Progesterone-Induced Blocking Factor in Mice Is Manifested by Modulating NK Activity
    Cellular Immunology, vol. 177, no. 2, pp. 194–199, 1997
  28. A Progesterone-Induced Protein Increases the Synthesis of Asymmetric Antibodies
    Cellular Immunology, vol. 167, no. 1, pp. 129–134, 1996
  29. A progesterone-dependent immunomodulatory protein alters the ? balance
    Journal of Reproductive Immunology, vol. 31, no. 1-2, pp. 81–95, 1996
  30. Natural lymphocyte cytotoxicity of women with different symptoms of toxemia
    European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 39, no. 2, pp. 133–137, 1991
  31. Antibody to hepatitis C virus in Hungary
    The Lancet, vol. 336, no. 8707, p. 123, 1990
  32. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody
    Cellular Immunology, vol. 125, no. 2, pp. 273–283, 1990
  33. On “the immunology of spontaneous abortion”
    Research in Immunology, vol. 141, no. 3, p. 261, 1990
  34. Progesterone-mediated immunosuppression and the maintenance of pregnancy
    Research in Immunology, vol. 141, no. 2, pp. 175–181, 1990
  35. Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction
    Cellular Immunology, vol. 122, no. 2, pp. 281–294, 1989
  36. Modulation of cell—cell and cell—antigen interactions by 1,25-dihydroxyvitamin D3 and vitamin D3 sulfate in vitro: a study on pregnancy lymphocytes and hybridoma cells
    Immunology Letters, vol. 20, no. 4, pp. 317–322, 1989
  37. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients
    Immunology Letters, vol. 22, no. 4, pp. 259–262, 1989
  38. ELISA test for the detection of an immunological blocking factor in human pregnancy serum
    Journal of Reproductive Immunology, vol. 16, no. 1, pp. 19–29, 1989
  39. Lymphocytic progesterone receptors in normal and pathological human pregnancy
    Journal of Reproductive Immunology, vol. 16, no. 3, pp. 239–247, 1989
  40. The blocking effect of PGE2 on lymphocyte reactivity in vitro is influenced by high concentrations of human serum
    Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 32, no. 2, pp. 83–85, 1988
  41. Rôle du placenta dans le maintien de l'allogreffe fétale
    Reproduction Nutrition Développement, vol. 28, no. 6B, pp. 1587–1598, 1988
  42. The suppressive effect of progesterone on lymphocyte cytotoxicity: unique progesterone sensitivity of pregnancy lymphocytes
    Journal of Reproductive Immunology, vol. 7, no. 2, pp. 121–128, 1985
  43. Immunosuppressive effect of serum progesterone during pregnancy depends on the progesterone binding capacity of the lymphocytes
    Journal of Reproductive Immunology, vol. 5, no. 2, pp. 81–88, 1983
  44. Influence of treatment with prostaglandin synthesis inhibitor or progesterone on cytotoxic activity and progesterone binding capacity of lymphocytes during pregnancy
    Prostaglandins, vol. 26, no. 2, pp. 187–195, 1983